Cellular Energy Based Investigational Study on Herpes Viruses

Dear Members,

I would like to provide some encouraging news to individuals battling recurrent outbreaks of herpes simplex virus (HSV) infections. Ongoing research not only indicates that acute herpetic lesions can be readily suppressed, but that the frequency of recurrences can be markedly reduced. The method being used is to activate an alternative cellular energy (ACE) pathway using light energized substances that make no direct contact with the patient.

The activating substances are termed enerceuticals and differ from pharmaceuticals in not being required to specifically localize to the site of illness.

The method is a significant advance on an earlier approach of applying neutral red dye to an active HSV lesion and illuminating with an ultraviolet light (Martin WJ, Stoneburner J. Symptomatic relief of herpetic skin lesions utilizing an energy based approach to healing. Exp. Mol. Path 2005; 78: 131-4.). Of particular significance, there is no longer the need to wait till an active lesion is present. Nor, as stated above, is there any need for direct contact of any dyes with the skin. This issue was of concern to the Food and Drug Administration (FDA) because of the remote possibility that neutral red dye could induce virus mutations that could conceivably lead to the emergence of more virulent viruses.

A research clinic has been established at Fort Smith, Arkansas to pursue these investigational studies. I am seeking support for this clinic from both herpes simplex and herpes zoster (shingles) infected patients who are able to cover the basic cost of the procedure and who may be willing to anonymously communicate their outcome to the wider herpes community. The results will also be conveyed to the Institutional Review Board (IRB) that is overseeing these studies.

Participation in these studies may not only be of benefit to herpes sufferers, but may also help in further developing energy based protocols for other illnesses. Indeed, IRB approval has been received to extend ACE activation studies to patients presumptively infected with viruses that evade immune recognition. Unlike conventional herpes viruses for which there is a cellular immune component, the control of these stealth adapted viruses is likely to be more dependent on the ACE pathway.

I would be pleased to provide additional details on the Fort Smith clinic and also to respond to e-mails either on this site or at s3support@mail.com

Kind regards, W. John Martin, MD, PhD.
Institute of Progressive Medicine
Burbank, CA 91502

* I thought it would be a good idea to post this information on the blog so that we could discuss it and maybe drum up some comments on the topic. I hope that the results are not going to be decided by the participants and that actual clinical studies will be conducted to verify the results of this particular study. Any feedback or knowledge of this effort is appreciated. Thanks! - Angela aka Yoshi2me

Filed under Yoshi2me's Buzz |